Given that the reduction of KIM-1 and NGAL is usually associated with mitigated kidney damage, it can be inferred that the improvement in eGFR may be linked to the decrease in KIM-1 and NGAL levels (Jacobson et al. 2021). The gene discussed is HAVCR1; the disease is Nephropathy.